Contemporary Clinical and Economic Outcomes Among Oral Anticoagulant Treated and Untreated Elderly Patients With Atrial Fibrillation: Insights from the United States Medicare Database

Abstract Background: Oral anticoagulants (OACs) mitigate the risk of stroke in atrial fibrillation (AF) patients. Objective: Elderly AF patients who were treated with OACs (apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin) were compared against AF patients who...